344 related articles for article (PubMed ID: 22363329)
1. Role of the HIV-1 Matrix Protein in Gag Intracellular Trafficking and Targeting to the Plasma Membrane for Virus Assembly.
Ghanam RH; Samal AB; Fernandez TF; Saad JS
Front Microbiol; 2012; 3():55. PubMed ID: 22363329
[TBL] [Abstract][Full Text] [Related]
2. Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH.
Fledderman EL; Fujii K; Ghanam RH; Waki K; Prevelige PE; Freed EO; Saad JS
Biochemistry; 2010 Nov; 49(44):9551-62. PubMed ID: 20886905
[TBL] [Abstract][Full Text] [Related]
3. Molecular Determinants of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for Assembly.
Herrmann D; Hanson HM; Zhou LW; Addabbo R; Willkomm NA; Angert I; Mueller JD; Mansky LM; Saad JS
J Mol Biol; 2022 Jun; 434(12):167609. PubMed ID: 35490898
[TBL] [Abstract][Full Text] [Related]
4. Molecular Determinants Directing HIV-1 Gag Assembly to Virus-Containing Compartments in Primary Macrophages.
Inlora J; Chukkapalli V; Bedi S; Ono A
J Virol; 2016 Oct; 90(19):8509-19. PubMed ID: 27440886
[TBL] [Abstract][Full Text] [Related]
5. Point mutations in the HIV-1 matrix protein turn off the myristyl switch.
Saad JS; Loeliger E; Luncsford P; Liriano M; Tai J; Kim A; Miller J; Joshi A; Freed EO; Summers MF
J Mol Biol; 2007 Feb; 366(2):574-85. PubMed ID: 17188710
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for targeting avian sarcoma virus Gag polyprotein to the plasma membrane for virus assembly.
Vlach J; Eastep GN; Ghanam RH; Watanabe SM; Carter CA; Saad JS
J Biol Chem; 2018 Dec; 293(49):18828-18840. PubMed ID: 30309983
[TBL] [Abstract][Full Text] [Related]
7. Membrane binding and subcellular localization of retroviral Gag proteins are differentially regulated by MA interactions with phosphatidylinositol-(4,5)-bisphosphate and RNA.
Inlora J; Collins DR; Trubin ME; Chung JY; Ono A
mBio; 2014 Dec; 5(6):e02202. PubMed ID: 25491356
[TBL] [Abstract][Full Text] [Related]
8. Structural Insights into the Mechanism of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for Assembly.
Herrmann D; Zhou LW; Hanson HM; Willkomm NA; Mansky LM; Saad JS
J Mol Biol; 2021 Sep; 433(19):167161. PubMed ID: 34298060
[TBL] [Abstract][Full Text] [Related]
9. Structural and molecular determinants of HIV-1 Gag binding to the plasma membrane.
Vlach J; Saad JS
Front Microbiol; 2015; 6():232. PubMed ID: 25852680
[TBL] [Abstract][Full Text] [Related]
10. The matrix domain of the Gag protein from avian sarcoma virus contains a PI(4,5)P
Watanabe SM; Medina GN; Eastep GN; Ghanam RH; Vlach J; Saad JS; Carter CA
J Biol Chem; 2018 Dec; 293(49):18841-18853. PubMed ID: 30309982
[TBL] [Abstract][Full Text] [Related]
11. Structural and biophysical characterizations of HIV-1 matrix trimer binding to lipid nanodiscs shed light on virus assembly.
Murphy RE; Samal AB; Vlach J; Mas V; Prevelige PE; Saad JS
J Biol Chem; 2019 Dec; 294(49):18600-18612. PubMed ID: 31640987
[TBL] [Abstract][Full Text] [Related]
12. Relationships between MA-RNA Binding in Cells and Suppression of HIV-1 Gag Mislocalization to Intracellular Membranes.
Thornhill D; Olety B; Ono A
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511376
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
Saad JS; Miller J; Tai J; Kim A; Ghanam RH; Summers MF
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11364-9. PubMed ID: 16840558
[TBL] [Abstract][Full Text] [Related]
14. Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag.
Inlora J; Chukkapalli V; Derse D; Ono A
J Virol; 2011 Apr; 85(8):3802-10. PubMed ID: 21289126
[TBL] [Abstract][Full Text] [Related]
15. Subcellular Localization of HIV-1
Becker JT; Sherer NM
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
[TBL] [Abstract][Full Text] [Related]
16. Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting.
Saad JS; Ablan SD; Ghanam RH; Kim A; Andrews K; Nagashima K; Soheilian F; Freed EO; Summers MF
J Mol Biol; 2008 Oct; 382(2):434-47. PubMed ID: 18657545
[TBL] [Abstract][Full Text] [Related]
17. Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein.
Mercredi PY; Bucca N; Loeliger B; Gaines CR; Mehta M; Bhargava P; Tedbury PR; Charlier L; Floquet N; Muriaux D; Favard C; Sanders CR; Freed EO; Marchant J; Summers MF
J Mol Biol; 2016 Apr; 428(8):1637-55. PubMed ID: 26992353
[TBL] [Abstract][Full Text] [Related]
18. Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure.
Ghanam RH; Fernandez TF; Fledderman EL; Saad JS
J Biol Chem; 2010 Dec; 285(53):41911-20. PubMed ID: 20956522
[TBL] [Abstract][Full Text] [Related]
19. Entropic switch regulates myristate exposure in the HIV-1 matrix protein.
Tang C; Loeliger E; Luncsford P; Kinde I; Beckett D; Summers MF
Proc Natl Acad Sci U S A; 2004 Jan; 101(2):517-22. PubMed ID: 14699046
[TBL] [Abstract][Full Text] [Related]
20. Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.
Jones CP; Datta SA; Rein A; Rouzina I; Musier-Forsyth K
J Virol; 2011 Feb; 85(4):1594-603. PubMed ID: 21123373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
